The three-hospital academic health system said that the losses are due to the cancellation of elective procedures coupled with increased expenses to boost diagnostic testing and acquire protective gear.
To help offset the losses, UW Medicine said it plans to take “urgent actions to reduce expenses.”
Those actions include pay cuts for senior leaders, staff furloughs and tight spending controls.
“I sincerely regret that our path to financial stability includes reductions in compensation, but I believe the actions we are taking will support the excellence of the UW Medicine clinical, research and educational programs,” said Paul Ramsey, MD, UW Medicine CEO.
The health system also plans to seek COVID-19 relief funds from federal and state programs.
UW Medicine said it will meet with faculty and staff to determine the extent of the cuts and discuss the full recovery plan.
More articles on healthcare finance:
Hospitals expect $200B hit from COVID-19 over 4 months
Walmart Health expands as physician practices face cash crunch
HHS doling out $22B to COVID-19 hotspots, rural hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
